Novo Nordisk terminated its deal with Hims & Hers Health. Separately, HSBC upgraded Nike stock to Buy from Hold, and CoreWeave is reportedly in talks to acquire Core Scientific.
2 reports, 0 independent
Updated Jun 28
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novo Nordisk terminated its deal with Hims & Hers Health. Separately, HSBC upgraded Nike stock to Buy from Hold, and CoreWeave is reportedly in talks to acquire Core Scientific.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CoreWeave
American cloud computing company
-
Core Scientific
company
-
Nike
American athletic equipment company
-
Hims & Hers Health
American telehealth company
Nothing else this week.
Related events
- A representative made specific stock market transactions on September 19, 2026, involving Novo Nordisk, PepsiCo, and JPMorgan Chase & Co.
- Novo Nordisk launched insulin in the US market.
- Novo Nordisk leadership undergoes changes amidst intensifying competition in the GLP-1 market, involving companies like Eli Lilly and Orion.
- Novo Nordisk operates in Europe, North America, the Middle East, and mainland China, while MarketBeat covers both Novo Nordisk and Eli Lilly.
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet